References
- Landers J, Martin K, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119(4), 694–702 (2012).
- Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL; Tube Versus Trabeculectomy Study Group. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am. J. Ophthalmol. 153(5), 789.e2–803.e2 (2012).
- AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am. J. Ophthalmol. 132, 311–320 (2001).
- Christakis PG, Kalenak JW, Zurakowski D et al. The Ahmed Versus Baerveldt study: one-year treatment outcomes. Ophthalmology 118(11), 2180–2189 (2011).
- Budenz DL, Barton K, Feuer WJ et al.; Ahmed Baerveldt Comparison Study Group. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology 118(3), 443–452 (2011).
- Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC; Tube Versus Trabeculectomy Study Group. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am. J. Ophthalmol. 153(5), 804.e1–814.e1 (2012).
- Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr. Opin. Ophthalmol. 23(2), 96–104 (2012).
- Jea SY, Mosaed S, Vold SD, Rhee DJ. Effect of a failed trabectome on subsequent trabeculectomy. J. Glaucoma 21(2), 71–75 (2012).
- Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Canaloplasty for primary open-angle glaucoma: long-term outcome. Br. J. Ophthalmol. 94(11), 1478–1482 (2010).
- Lewis RA, von Wolff K, Tetz M et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study results. J. Cataract Refract. Surg. 35(5), 814–824 (2009).
- Mesci C, Erbil HH, Karakurt Y, Akçakaya AA. Deep sclerectomy augmented with combination of absorbable biosynthetic sodium hyaluronate scleral implant and mitomycin C or with mitomycin C versus trabeculectomy: long-term results. Clin. Experiment. Ophthalmol. 40(4), e197–e207 (2012).
- Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, Fernández-Pérez C, García-Sánchez J, García-Feijoó J. Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br. J. Ophthalmol. 96(5), 645–649 (2012).
- Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE; US iStent Study Group. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 118(3), 459–467 (2011).
- Craven ER, Katz LJ, Wells JM, Giamporcaro JE; iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J. Cataract Refract. Surg. 38(8), 1339–1345 (2012).
- Minckler D, Baerveldt G, Ramirez MA et al. Clinical results with the Trabectome, a novel surgical device for treatment of open-angle glaucoma. Trans. Am. Ophthalmol. Soc. 104, 40–50 (2006).